BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 16738955)

  • 1. Biological therapies directed against cells in autoimmune disease.
    Hasler P
    Springer Semin Immunopathol; 2006 Jun; 27(4):443-56. PubMed ID: 16738955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [B cells as key contributors in determining the level of immune responses -B-cell-targeted therapy in patients with autoimmune diseases].
    Kondo S; Akashi T; Katsuta H; Iwakiri R; Anzai K; Nagafuchi S; Niho Y; Harada M
    Fukuoka Igaku Zasshi; 2005 Apr; 96(4):86-92. PubMed ID: 15991605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Translational Mini-Review Series on B Cell-Directed Therapies: B cell-directed therapy for autoimmune diseases.
    Hu C; Wong FS; Wen L
    Clin Exp Immunol; 2009 Aug; 157(2):181-90. PubMed ID: 19604257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenic functions of B cells in autoimmune diseases: IFN-γ production joins the criminal gang.
    Fillatreau S
    Eur J Immunol; 2015 Apr; 45(4):966-70. PubMed ID: 25727209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Green tea EGCG, T cells, and T cell-mediated autoimmune diseases.
    Wu D; Wang J; Pae M; Meydani SN
    Mol Aspects Med; 2012 Feb; 33(1):107-18. PubMed ID: 22020144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New therapies in development for autoimmune diseases: their rationale for combination treatment.
    Strand V
    Springer Semin Immunopathol; 2001; 23(1-2):43-61. PubMed ID: 11455860
    [No Abstract]   [Full Text] [Related]  

  • 7. B-cell depletion in autoimmune diseases. Advances in autoimmunity.
    Guzman Moreno R
    Autoimmun Rev; 2009 Jun; 8(7):585-90. PubMed ID: 19393204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of the T cell in autoimmune inflammation.
    Skapenko A; Leipe J; Lipsky PE; Schulze-Koops H
    Arthritis Res Ther; 2005; 7 Suppl 2(Suppl 2):S4-14. PubMed ID: 15833146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The therapeutic potential of anti-CD20 "what do B-cells do?".
    Eisenberg R; Looney RJ
    Clin Immunol; 2005 Dec; 117(3):207-13. PubMed ID: 16169773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. B cells as a therapeutic target in autoimmune disease.
    Goronzy JJ; Weyand CM
    Arthritis Res Ther; 2003; 5(3):131-5. PubMed ID: 12723978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. B-cells and their targeting in rheumatoid arthritis--current concepts and future perspectives.
    Nakken B; Munthe LA; Konttinen YT; Sandberg AK; Szekanecz Z; Alex P; Szodoray P
    Autoimmun Rev; 2011 Nov; 11(1):28-34. PubMed ID: 21777703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B-cell targeted therapies in human autoimmune diseases: an updated perspective.
    Townsend MJ; Monroe JG; Chan AC
    Immunol Rev; 2010 Sep; 237(1):264-83. PubMed ID: 20727041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crossroads of B cell activation in autoimmunity: rationale of targeting B cells.
    Dörner T
    J Rheumatol Suppl; 2006 May; 77():3-11. PubMed ID: 16652439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunotherapeutic Targeting in Autoimmune Diseases.
    Janikashvili N; Samson M; Magen E; Chikovani T
    Mediators Inflamm; 2016; 2016():1432702. PubMed ID: 28074079
    [No Abstract]   [Full Text] [Related]  

  • 15. B cell reductive therapy in the treatment of autoimmune diseases: a focus on monoclonal antibody treatment of rheumatoid arthritis.
    Tuscano JM; Martin S; Song K; Wun T
    Hematology; 2005 Dec; 10(6):521-7. PubMed ID: 16321818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [New therapeutic approaches to autoimmune diseases].
    Amoura Z; Piette JC
    Presse Med; 2006 Apr; 35(4 Pt 2):709-13. PubMed ID: 16614619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B cell-directed therapies for autoimmune disease and correlates of disease response and relapse.
    Levesque MC; St Clair EW
    J Allergy Clin Immunol; 2008 Jan; 121(1):13-21; quiz 22-3. PubMed ID: 18206502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The humoral response in rheumatoid arthritis and the effect of B-cell depleting therapy].
    Thurlings RM; Vos K; Gerlag DM; Tak PP
    Ned Tijdschr Geneeskd; 2006 Jul; 150(30):1657-61. PubMed ID: 16922350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B cells participate in tolerance and autoimmunity through cytokine production.
    Luu VP; Vazquez MI; Zlotnik A
    Autoimmunity; 2014 Feb; 47(1):1-12. PubMed ID: 24245950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role and clinical implications of G6PI in experimental models of rheumatoid arthritis.
    Kamradt T; Schubert D
    Arthritis Res Ther; 2005; 7(1):20-8. PubMed ID: 15642150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.